International Journal of Cardiology
Volume 134, Issue 2 , Pages 180-188 , 15 May 2009

The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography

  • Jun Tanigawa

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • First Department of Internal Medicine, Osaka Medical College, Osaka, Japan
    • ,
  • Peter Barlis

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • ,
  • Konstantinos Dimopoulos

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, United Kingdom
    • ,
  • Miles Dalby

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • ,
  • Philip Moore

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • ,
  • Carlo Di Mario

      Affiliations

    • Department of Cardiology, Royal Brompton & Harefield NHS Trust, London, United Kingdom
    • Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, United Kingdom
    • Corresponding Author InformationCorresponding author. Royal Brompton Hospital, Sydney Street, SW3 6NP London, United Kingdom. Tel.: +44 20 7352 8121; fax: +44 20 7351 8473.

Received 11 February 2008 ,Accepted 10 May 2008.

References 

  1. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005;112:3306–3313
  2. Urban P, Gershlick AH, Guagliumi G, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation. 2006;113:1434–1441
  3. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Jama. 2005;293:2126–2130
  4. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–1113
  5. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426–2434
  6. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202
  7. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108–2111
  8. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678
  9. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–2441
  10. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500–1510
  11. Rittersma SZ, de Winter RJ, Koch KT, et al. Impact of strut thickness on late luminal loss after coronary artery stent placement. Am J Cardiol. 2004;93:477–480
  12. Tanigawa J, Barlis P, Di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention. 2007;3:128–136
  13. Kawase Y, Hoshino K, Yoneyama R, et al. In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: a comparison with intravascular ultrasound. Ultrasound Med Biol. 2005;31:1343–1349
  14. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004;109:881–886
  15. Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111:900–905
  16. Suzuki Y, Ikeno F, Yeung AC. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol. 2006;18:111–114
  17. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–967
  18. Takano M, Inami S. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007;99:1033–1038

PII: S0167-5273(08)00764-X

doi: 10.1016/j.ijcard.2008.05.069

International Journal of Cardiology
Volume 134, Issue 2 , Pages 180-188 , 15 May 2009

Article Tools

* Image Usage & Resolution